RLAY

RELAY THERAPEUTICS, INC.

RLAY · CIK 1812364 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$15M
20202025
Net Income−$276M
20202025
Operating CF−$235M
20202025
Free Cash Flow−$236M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B
Cost of Revenue——————
Gross Profit——————
R&D Expense—————$0.1B
SG&A Expense——————
Operating Income$-0.3B$-0.4B$-0.4B$-0.3B$-0.4B$-0.1B
Net Income$-0.3B$-0.3B$-0.3B$-0.3B$-0.4B$-0.1B
EPS (Basic)$-1.61$-2.36$-2.79$-2.59——
EPS (Diluted)$-1.61$-2.36$-2.79$-2.59——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.6B$0.9B$0.8B$1.1B$1.0B$0.8B
Current Assets$0.6B$0.8B$0.8B$1.0B$1.0B$0.8B
Cash & Equivalents$0.1B$0.1B$0.1B$0.2B$0.3B$0.4B
Total Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
Current Liabilities$0.0B$0.1B$0.0B$0.1B$0.0B$0.0B
Stockholders' Equity$0.6B$0.8B$0.8B$1.0B$0.9B$0.8B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.2B$-0.2B$-0.3B$-0.2B$-0.1B$-0.1B
Investing Cash Flow$0.2B$-0.0B$0.3B$-0.2B$-0.5B$0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.3B$0.0B$0.3B$0.4B$0.4B
← Companies